chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine and within 10 minutes she felt like her heart did a big woosh and was sitting with her husband and told him that it was hitting her blood stream as she had not had the reaction since starting some medication due to lupus.  The first hour it was fairly overwhelming wooshing sensation that made her feel uncomfortable and restless, and then got less.  Over the course of the week it continued to happen and did not feel right.  She called her PCP and by the time she got to see him  on 5/20/21 it had been a month, but had not worsened to go to the ER.  She had an EKG that showed acquired long QT syndrome, and told her that she could not get the 2nd vaccine.   He said that if she got hte 2nd vaccine that there was a likelihood that she would develop Torsades de pointes and that it could be life threatening.  Now he has to be careful on what to treat her due to this condition.   He told her to take really good care of herself and to continue take her medications and if it got worse to go to the ER.  She will FU with him in a month and he would continue to check EKG's to see if it will go away or not.   She is more tired and if she goes up and down the steps she is out of breath much quicker than before this condition.  She had several  normal EKG's in the past that he compared the last one with and she did not have this condition on previous EKG's.    She wishes that they would put out information for people who have autoimmune issues to publish these reactions to be watchful of reactions.  Feels they need to update the website to report similar side effects.
55 hours after  vaccine malaise then fear then rigors.  Loss appetite,  right temple pain.   59 hr after joint pains and beginning rash left lower leg.   Minimal benefit acetaminophen.  generalized joint pain but severe pain left lower over right lower extremity.  60 hr after hard to walk 2nd pain left lower leg and rash -b4 blotches  red, hot  tender   no tracking.  Exquisite pain left over right lower extremity especially left ankle area.  Hard to bare weight especially on 1srt standing.  Very tender along tibia esp lower.  72 yours can barely drink soup or applesauce.  Hard to walk.  Urine dark.  78 hrs  took 1 gr cefalexin and 30 mg prednisone.  Within 3 hours could sleep.   Slowly malaise and fear ease.  Pain left lower leg prominent and rash tender warm red dark.   98 hours  start  Prednisone 25 mg a day and tapering 2.5 mg down ever 3 days.   By 5 days much improved but residual swelling and pain left lower leg.  med over lat malleolus and tenderness lower med soft tissue
Around 10  minutes after injection, she developed symptoms that included nausea, dizziness, and syncope.  Symptoms progressed over time until she seemed almost catatonic at times including delayed responses, staring straight ahead (later she closed her eyes), slurred speech.  She kept repeating, "I feel like jelly" and that she was very tired.  Pharmacist gave her 25 mg diphenhydramine at 10:55 am.  Around 11:10 the facilities administer called 911 at the request of  (PharmD).
No adverse effects reported; She reported that on 10/5/2016 and l l/30/2016, the 13 year old patient was administered doses of PROQUAD; Inappropriate age at vaccine administration; This spontaneous report was received from a registered nurse and refers to a 13-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions, allergies and concomitant therapies were not reported.  On 05-OCT-2016, the patient was vaccinated with the first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA), lot # M015698, expiration date not provided but upon internal validation established as 26-SEP-2017 (strength, dose and route of administration were not provided) for prophylaxis and on 30-NOV-2016, the patient was vaccinated with the second dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) recombinant human albumin (rHA), lot # M015698, expiration date not provided but upon internal validation established as 26-SEP-2017 (strength, dose and route of administration were not provided) for prophylaxis (inappropriate schedule of product administration and product administered to patient of inappropriate age). No adverse effects were reported. The outcome of the events was unknown.
covid-19vaccine EUA     received shot on Monday on Wednesday expierenced swelling of lymph noid in  groin left side applied hot compress   went down but has not disapeared tuesday  Jan 26
Chills and pretty cold last night. Headache all night last night. Took Tylenol for it. It felt better but it's back. Had vaccination at facility.
Parsinage Turner Syndrome bilateral.  First onset right brachial plexus 11/2/2021.  Opiod level pain until early December 2021.  Onset left shoulder December 2,2021 with rotator cuff like symptoms.  Mild right and moderate left side discomfort persists 12/30/2021.  Approximate 75% loss of strength right upper arm and shoulder girdle.  Approximate 40% loss of strength left shoulder, mostly limited by pain on shoulder abduction and rotation.  C4-T1 right.  C4-C5 left.
98.9 x 4 days-headache and body aches x 4 days. No rash or hives.
Myalgia, Fever, inj site lump (took off the 4th) Narrative:
Per patient: heads up on my reaction to the Flu/pneumococcal vaccines. I know the flu vaccines vary year to year and the reactions are sometimes recorded. My arm felt like it had been punched by 4pm the day of, not uncommon, I know. Within an hour feeling it coming on: light headed, leg aches, and arm increasingly sore. By 10 pm chills. Next day, still not feeling top notch, arm still in poor shape. In fact soreness spreading to inner bicep area. That night still getting chills. Barely lift my arm above shoulder level. Finally, next day I felt fine except for the arm. Bicep swollen and hives from inner bicep down to elbow. Yesterday, inner elbow was swollen. Some itching on upper arm as well. Good news, this morning arm is greatly improved and betting I am past this. I realize these may be common results of this years vaccine, but I also read there is a reporting agency that tracks this. So mainly this is a heads up to you.
Developed severe chills, body aches, mild fever of 100.5. Lasted about 30 hours. Treated with Tylenol. Had to miss a day of work. Have lingering fatigue and headache after 2 days.  Also morning after vaccination had about 5 minutes of tachycardia with HR of 165 bpm. Resolved after taking blood pressure which was 114/69 with HR of 85 bpm. No further episodes.
Chills; Fever; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of chills in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 26-SEP-2023, the patient received the 1st dose of Shingrix. On 27-SEP-2023, 1 days after receiving Shingrix, the patient experienced chills (Verbatim: Chills) and fever (Verbatim: Fever).The outcome of the chills and fever were resolved.   It was unknown if the reporter considered the chills and fever to be related to Shingrix.     It was unknown if the company considered the chills and fever to be related to Shingrix.   Additional Information: GSK Receipt Date: 28-SEP-2023 This case was reported by a patient's wife via interactive digital media. The reporter stated that Shingrix was a 2-part vaccination.  The patient had part 1 and the day before reporting he was down with chills and fever all day. The follow up would not possible as no contact details were available.
I became weak and thought I was going to faint. I called the medical professional over and they brought me into a staged area for triage. My blood pressure was 171/ 104 or 114. I had chest pain. The EMT did and EKG, listened to my heart, and started an IV. The ambulance was called and I was transported by ambulance to the hospital. At the hospital another EKG was taken, blood pressure and blood work. Repeated blood work was taken. I was admitted to the hospital due to elevation of tyoponin level and chest pain. The following day 1/22/21 I saw my PCP and he thought it was related to the vaccine and recommended a cardiologist for the increased levels of tyoponin and chest pain.  The cardiologist performed another EKG< more blood work and performed a cardiac catheterization and a ECO. Both were normal. Prior to that I was given a nitro pill as my chest pain was between a 7 and a 8; a few minutes later the nurse asked about my pain level and it was a 3-4. I was given another nitro pill and shortly after I felt extremely faint and my blood pressure was 56/32. I was immediately given a bolus of saline IV . The chest pain continued through the day. The following day, I had no further chest pain, my tyoponin levels returned to normal and I was released from the hospital.
The patients were given vaccine that was stored in refrigerator for more than 30 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The patients were given vaccine that was stored in refrigerator for more than 30 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025C21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (The patients were given vaccine that was stored in refrigerator for more than 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The patients were given vaccine that was stored in refrigerator for more than 30 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was  not sure if it was 1st or 2nd dose for patients. The vaccine was given on 03Jun2021 from 1 vial and 07Jun2021 from another vial with same batch number and expiration date.  Concomitant product use was not provided by the reporter.  Treatment information was not provided.
I also got palpitations and chest tightness; I also got palpitations and chest tightness; My left hand got swollen in the afternoon and it lasted all night; This is a spontaneous report from a contactable consumer (patient). A 27-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCIN, Lot Number: EW0181), via an unspecified route of administration, administered in arm left on 05Jul2021 09:30 (at the age of 27-year-old) as dose 1, single for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication included pantoprazole. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took carbamazepine and experienced drug allergy. The patient stated her left hand got swollen in the afternoon and it lasted all night, the day after she got the vaccine on 06Jul2021 19:00. She also got palpitations and chest tightness on 06Jul2021 19:00. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19 (PCR and RDT): Negative on 02Jul2021 (Nasal Swab). No treatment was received as a result of the events. The event outcome was unknown.  Follow-up attempts are completed. No further information is expected.
Had nausea @ 1:00am for about an hour and than at 4:30am had the worse chills of my life. Than at around @ 7:30 am I awoke to my body being covered in what I thought was chicken pox. This event all happened on 8/1/21 the day after my vaccine shot.
Patient was diagnosed with COVID-19; Patient was diagnosed with COVID-19; This is a spontaneous report from a non-contactable pharmacist.  A 25-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 2 via an unspecified route of administration on 30Apr2021 at the age of 25-years-old as dose 2, single, dose 1 via an unspecified route of administration on 09Apr2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization. Medical history included anxiety from an unknown date and unknown if ongoing. Concomitant medication included fluoxetine taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the Covid vaccine.The patient received other medications of vaccination. The patient was not diagnosed with Covid 19 and has been tested for Covid-19 Since the vaccination. On 01Aug2021 the patient experienced patient was diagnosed with covid-19, experiencing loss of smell, loss of taste, sore throat, cough, mild congestion, similar to seasonal allergies. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 01Au g2021. The outcome of events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the information provided the lack of efficacy of the vaccine BNT162B2 cannot be excluded. The case will be reassessed if any new information is reported.
Red/bruise like marks on backs of both hands and small bruising on right foot appeared late on Saturday 4/10/2021. Blood in stool on Sunday 4/11/2021.
Nose sores and raw tongue.  Fever 101.6 Chills, Swelling, High Blood Sugar 442 constipation, blurred vision, very weak.  My husband had to guide me to restroom and back to bed.  These were the only times I was up and mobile.  Muscle and joint pain
COVID-19  Vaccine EUA   I had a sore arm at the spot;  then I was in a sleepy condition.  Then I took 2,  81 mg aspirins.
Sporadic menstruation, despite continued use of birth control since administration of vaccine.  Bleeding occurs for 2 to 3 weeks out of the month.  Doubling up on birth control tablets stops bleeding, but only temporarily.
(tongue, hand, trunk: lasting <12hours) No associated hives. Angio-edema starting 1-2 weeks for anthrax #2 (FAV 076). Symptoms continued x 6 months and did not have specific relation to shots except temporal onset association. Last anthrax 9/03. Last angioedema 3/04.
Localized skin reaction 8x6 rash/wheal extending beyond the injection site with discomfort resulting in additional health care visit and prescribed topical Westcort cream, antihistamine and symptomatic home treatment.
Gout; Body aches; Swollen glands; Headaches; Fever of 101; This spontaneous case was reported by a consumer and describes the occurrence of GOUT (Gout), PAIN (Body aches), LYMPHADENOPATHY (Swollen glands), HEADACHE (Headaches) and PYREXIA (Fever of 101 F) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GOUT (Gout), PAIN (Body aches), LYMPHADENOPATHY (Swollen glands), HEADACHE (Headaches) and PYREXIA (Fever of 101 F). At the time of the report, GOUT (Gout), PAIN (Body aches), LYMPHADENOPATHY (Swollen glands), HEADACHE (Headaches) and PYREXIA (Fever of 101 F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Rash c/w Pityriasis Rosea distribution and appearance. Not seen in office for rash until 11/28/09.
Itching in area of injection in left arm. Area also red, swollen and hot to the touch. Sx began in AM of 12/9/03 continuing today. No relief with Tylenol, Benadryl or cold packs to area. Seen by PMD. Dx: cellulitis. Being treated with Keflex.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 01Nov2022 as dose 4 (booster), single (Lot number: GJ6665) at the age of 43 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: 4 days of testing negative followed by positive test on day 5; Positive, notes: 4 days of testing negative followed by positive test on day 5. Therapeutic measures were taken as a result of drug ineffective, covid-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300207327 Same reporter/patient,different drug/AE.;
For my symptoms i had body ache hard time breathing headaches nausea.  chest tightness and back pain and leg pain.  swollen lymph node and saw a doctor for that. Fatigue.
Approximately 15mins.  after receiving 2nd dose PT. c/o "tingling"to her lips.  PT. moved to treatment area where she was assessed and vitals and history obtained.  PT. denied any other symptoms other than the tingling.  PT. given 25mg of Benadryl and observed.  After approximately 20mins.  pt. stated the tingling had subsided.  PT. vitals taken again and PT. observed another 10mins.  PT. released with her mother and both were advised to seek further medial attention or call 911 with any further problems.
Urticaria and hives on large part of the body. Chills and generalized pain. This occurred approximately 6 hour after injection of the vaccine it was treated with BENADRYL (100 mg) and Prednisone 40 mg and symptoms improved after 60 min. Patient was treated by visiting home physician.
neck pain/neck sore; headache; A report was received from a consumer who was also a female patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced neck pain/neck sore and headache.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 30 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 31 Dec 2020, the patient experiencing neck pain/neck sore and headache.   Treatment for the event included paracetamol and the symptoms subsided, but then returned.  Action taken with mRNA-1273 in response to the events was not reported.  The outcomes of the events, neck pain/neck sore and headache were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Left upper arm with swelling, warm, pink. 10x13 1/2 cm.
PATIENT BEGAN TO FEEL FLUSHED IN CHEST AREA AND FACE AND BECAME NAUSEOUS. HE ALSO FELT COLD.
One day post vax, this pt presented complaining of redness, swelling, and warmth around injection site - right deltoid. Right arm edematous, right arm warm to touch, erythematous and indurated at injection site. She recovered.
Alopecia which he states began 24 hrs after second dose of Hbv. Alopecia still present
- Flu-like symptoms on Days 2 and 3 after vaccine - On Day 4 after vaccine, developed marked swelling, pain, and redness around injection site; lasted for 3 days before swelling subsided, but redness and firmness of tissue around injection site persisted - On Day 9 after vaccine, developed "Covid Arm"; heavy swelling, itching, and redness over entirety of upper left arm. Swelling did not respond to Benadryl. No other allergy symptoms (hives elsewhere, etc.) - Filing this report on Day 16 after vaccine and, while swelling has improved, itching persists and I still have a walnut-sized mass of firm tissue under skin near injection site and patch of redness/discoloration on deltoid. Have been checked by doctor who ensured that reaction is indeed dermatological allergic reaction (not infection).
This case was reported by a pharmacist via call center representative and described the occurrence of injection site rash in a 50-year-old female patient who received Shingrix (batch number ZG47A, expiry date 12th February 2021) for prophylaxis. On 12th August 2018, the patient received Shingrix (intramuscular) .5 ml. On 13th August 2018, 1 days after receiving Shingrix, the patient experienced injection site rash and axillary lymph nodes enlarged. On an unknown date, the outcome of the injection site rash and axillary lymph nodes enlarged were unknown. It was unknown if the reporter considered the injection site rash and axillary lymph nodes enlarged to be related to Shingrix. Additional details reported as follows: The pharmacist reported that, the patient developed a rash on her arm where she got Shingrix, and also had a swollen lymph node under her arm.
Patient developed high fever, chills, sweats, cough, upper respiratory symptoms, muscle aches that began that evening. Reported to me by patient on 10/12/2010. Patient has missed 2 days of work due to this so far, likely more.
pt recv vax 5AUG98 exp itching;3 days later 8AUG98 pt devel purple spots on torso;
Headache; Injections site pain; Myalgia; Malaise; This is a spontaneous report from a non-contactable physician (patient). A 27-years-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular at left arm on 09Jan2021 16:00 at single dose for COVID-19 immunization. Medical history was reported as none and no known allergies. The patient's concomitant medications were not reported. The historical vaccine included first dose of BNT162B2 intramuscular at left arm on 19Dec2020 16:00 for COVID-19 immunization. The patient experienced headache, injections site pain, myalgia, malaise on 10Jan2021 09:00 with outcome of recovering. No treatment received for the adverse events. No COVID prior vaccination, since the vaccination the patient hadn't been tested for COVID-19.  No follow-up attempts are possible, information about batch number cannot be obtained.
1015 demonstrated flushed cheeks, splotchy red rash on lower extremities; became irritable pt apprehensive, generalized urticaria; 1020 DPH, BP 124/78, pulse 120; 1030 Pred, 1035 Adrenalin; 1040 t98,6 ax; 1045 color returning to nl;
pt fainted p/vax, slipped from mom lap onto floor, unconscious about 1min, clammy, ammonia ampule used;pt aroused sat in chair-emesis about 50cc became drowsy-faint again placed on stretcher & 911 called;BP 70/50-100/60;